ABBV
AbbVie Inc.
NYSE · USHealthcareDrug Manufacturers - General
$253.38-0.44%
Price as of Jul 20, 2026
ABBV valuation
AbbVie Inc. valuation
Trailing, forward and enterprise-value multiples for the requested listing.
Forward multiples
- P/E forward
- 16.73x
- P/E 2026E
- 17.40x
- P/E 2027E
- 15.64x
- P/E 2028E
- 14.18x
- P/S forward
- 6.50x
Trailing multiples
- P/E TTM
- 124.24x
- PEG TTM
- 0.19x
- Price / book
- 16.28x
- Price / sales
- 7.13x
- Price / cash flow
- 21.09x
Enterprise value
- Enterprise value
- $511.2B
- EV / sales
- 8.14x
- EV / EBITDA
- 30.21x
- EV / EBIT
- 29.48x
- Market cap
- $447.7B
Latest available reported and market-derived figures. A dash means the source dataset does not currently cover that metric; it does not imply a zero value.